7-Azido-heptan-2-one | 84702-79-4

• 分子结构分类: 有机化合物 - 有机1,3-偶极化合物 - 烯丙基型1,3-偶极有机化合物
• 英文名称: 7-Azido-heptan-2-one
• 英文别名: 7-Azidoheptan-2-one
• CAS: 84702-79-4
• 化学式: C₇H₁₃N₃O
• 分子量: 155.2
• InChiKey: OTSNAKWCAKJTRD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  11
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  31.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  7-Azido-heptan-2-one 在 三苯基膦 作用下， 以 乙醚 为溶剂， 以60%的产率得到2-methyl-4,5,6,7-tetrahydro-3H-azepine
  参考文献：
  名称：

  一种新型有效的环状亚胺

  摘要：

  可以通过分子内的“氮杂-维蒂希”反应由ω-叠氮酮方便地制备环状亚胺。

  DOI：

  10.1039/c39820001224
• 作为产物：
  描述：

  7-chloroheptan-2-one 在 sodium iodide sodium azide 作用下， 以 二甲基亚砜 为溶剂， 反应 18.0h， 以88%的产率得到7-Azido-heptan-2-one
  参考文献：
  名称：

  Vaultier, M.; Lambert, P. H.; Carrie, R., Bulletin de la Societe Chimique de France, 1986, # 1, p. 83 - 92

  摘要：

  DOI：

文献信息

• PROBE FOR IMAGING PARP-1 ACTIVITY
  申请人：The Board of Trustees of the Leland Stanford Junior University

  公开号：US20160185805A1

  公开（公告）日：2016-06-30

  Provided are embodiments of a small molecule tracer for positron emission tomography (PET) imaging of the enzyme activity of PARP-1 that is responsible for DNA-damage sensing and critically involved in radiation therapy and some chemotherapy response mechanisms. These PARP-1 tracers are derivatives of nicotinamide adenine dinucleotide (NAD), which is the natural substrate for PARP-1. Provided are NAD derivatives that include a linker moiety to which may be attached a label moiety such as a PET detectable fluorine to generate a 6N-(triazo-PEG2- 18 F)-NAD. Especially advantageous for use in PET and MRI scanning detection systems is the attachment of a chelating agent that allows for the formation of a chelator-metal ion complex.

  提供了一种用于正电子发射断层扫描（PET）成像PARP-1酶活性的小分子示踪剂的实施例，PARP-1酶负责DNA损伤感知，在放射治疗和一些化疗反应机制中起着关键作用。这些PARP-1示踪剂是烟酰胺腺嘌呤二核苷酸（NAD）的衍生物，NAD是PARP-1的天然底物。提供了包括连接基团的NAD衍生物，可以附加标记基团，如PET可检测的氟，以生成6N-(triazo-PEG2-18F)-NAD。尤其适用于PET和MRI扫描检测系统的是连接螯合剂的附着，允许形成螯合剂-金属离子复合物。
• Non-Peptide Macrocyclic Histone Deacetylase (HDAC) Inhibitors and Methods of Making and Using Thereof
  申请人：Oyelere Adegboyega

  公开号：US20100197622A1

  公开（公告）日：2010-08-05

  Compounds of Formula I or II, and methods of making and using thereof, are described herein. M represents a macrolide subunit, n is a C 1-6 group, optionally containing one or more heteroatoms, D is an alkyl or aryl group, A is a linking group connected to D, B is an alkyl, alkylaryl or alkylheteroaryl spacer group, ZBG is a Zinc Binding Group, R 1 , R 2 and R 4 are independently are selected from hydrogen, a C1-6 alkyl group, a C 2-6 alkenyl group, a C 2-6 alkynyl group, a C 1-6 alkanoate group, a C 2-6 carbamate group, a C 2-6 carbonate group, a C 2-6 carbamate group, or a C 2-6 thiocarbamate group, R 3 is hydrogen or —OR 5 , R 5 is selected from a group consisting of Hydrogen, a C 1-6 alkyl hgroup, a C 2-6 alkenyl group, a C 2-6 alkynyl group, C 1-6 alkanoate group, C 2-6 carbamate group, C 2-6 carbonate group, C 2-6 carbamate group, or C 2-6 thiocarbamate group.

  本文描述了公式I或II的化合物，以及制备和使用它们的方法。其中，M代表大环内酯亚基，n是C1-6基团，可选地含有一个或多个杂原子，D是烷基或芳基基团，A是连接到D的连接基团，B是烷基、烷基芳基或烷基杂芳基间隔基团，ZBG是锌结合基团，R1、R2和R4独立地选择自氢、C1-6烷基、C2-6烯基、C2-6炔基、C1-6烷酸酯基、C2-6氨基甲酸酯基、C2-6碳酸酯基、C2-6氨基甲酸酯基或C2-6硫代氨基甲酸酯基，R3是氢或-OR5，R5选择自氢、C1-6烷基、C2-6烯基、C2-6炔基、C1-6烷酸酯基、C2-6氨基甲酸酯基、C2-6碳酸酯基、C2-6氨基甲酸酯基或C2-6硫代氨基甲酸酯基的一组。
• NON-PEPTIDE MACROCYCLIC HISTONE DEACETYLASE (HDAC) INHIBITORS AND METHODS OF MAKING AND USING THEREOF
  申请人：Oyelere Adegboyega

  公开号：US20120329741A1

  公开（公告）日：2012-12-27

  Compounds of Formula I or II, and methods of making and using thereof, are described herein. M represents a macrolide subunit, E is a C 1-6 group, optionally containing one or more heteroatoms, D is an alkyl or aryl group, A is a linking group connected to D, B is an alkyl, alkylaryl or alkylheteroaryl spacer group, ZBG is a Zinc Binding Group, R 1 , R 2 and R 4 are independently are selected from hydrogen, a C1-6 alkyl group, a C 2-6 alkenyl group, a C 2-6 alkynyl group, a C 1-6 alkanoate group, a C 2-6 carbamate group, a C 2-6 carbonate group, a C 2-6 carbamate group, or a C 2-6 thiocarbamate group, R 3 is hydrogen or —OR 5 , R 5 is selected from a group consisting of Hydrogen, a C 1-6 alkyl group, a C 2-6 alkenyl group, a C 2-6 alkynyl group, C 1-6 alkanoate group, C 2-6 carbamate group, C 2-6 carbonate group, C 2-6 carbamate group, or C 2-6 thiocarbamate group.

  本文描述了I或II式化合物及其制备和使用方法。其中，M代表大环内酯亚基，E为C1-6基团，可选含有一个或多个杂原子，D为烷基或芳基基团，A为连接到D的连接基团，B为烷基、烷基芳基或烷基杂芳基间隔基团，ZBG为锌结合基团，R1、R2和R4独立地选择自氢、C1-6烷基、C2-6烯基、C2-6炔基、C1-6烷酸酯基、C2-6氨基甲酸酯基、C2-6碳酸酯基、C2-6氨基甲酰基或C2-6硫代氨基甲酰基，R3为氢或-OR5，R5选择自氢、C1-6烷基、C2-6烯基、C2-6炔基、C1-6烷酸酯基、C2-6氨基甲酸酯基、C2-6碳酸酯基、C2-6氨基甲酰基或C2-6硫代氨基甲酰基。
• LAMBERT, P. H.;VAULTIER, M.;CARRIE, R., J. CHEM. SOC. CHEM. COMMUN., 1982, N 21, 1224-1225
  作者：LAMBERT, P. H.、VAULTIER, M.、CARRIE, R.

  DOI：——

  日期：——
• VAULTIER, M.;LAMBERT, P. H.;CARRIE, R., BULL. SOC. CHIM. FR., 1986, N 1, 83-92
  作者：VAULTIER, M.、LAMBERT, P. H.、CARRIE, R.

  DOI：——

  日期：——